A.M. Kroon

3.1k total citations
80 papers, 2.4k citations indexed

About

A.M. Kroon is a scholar working on Molecular Biology, Clinical Biochemistry and Oncology. According to data from OpenAlex, A.M. Kroon has authored 80 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 23 papers in Clinical Biochemistry and 10 papers in Oncology. Recurrent topics in A.M. Kroon's work include Mitochondrial Function and Pathology (34 papers), Metabolism and Genetic Disorders (23 papers) and RNA and protein synthesis mechanisms (13 papers). A.M. Kroon is often cited by papers focused on Mitochondrial Function and Pathology (34 papers), Metabolism and Genetic Disorders (23 papers) and RNA and protein synthesis mechanisms (13 papers). A.M. Kroon collaborates with scholars based in Netherlands, Italy and United Kingdom. A.M. Kroon's co-authors include Piet Borst, Coby Van den Bogert, G.J.C.M. Ruttenberg, Marijke Holtrop, E.F.J. Van Bruggen, H. de Vries, Cecilia Saccone, G.S.P. Groot, Jan‐Willem Taanman and Frits H. Roerdink and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

A.M. Kroon

80 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Kroon Netherlands 30 1.7k 496 241 181 172 80 2.4k
Isamu Matsumoto Japan 32 1.9k 1.1× 264 0.5× 239 1.0× 133 0.7× 184 1.1× 124 3.0k
Wieland Gevers South Africa 26 1.6k 0.9× 149 0.3× 300 1.2× 158 0.9× 343 2.0× 95 2.7k
Richard M. Wright United States 32 1.8k 1.1× 152 0.3× 183 0.8× 92 0.5× 177 1.0× 75 2.9k
Mary Jane Spiro United States 32 1.9k 1.1× 207 0.4× 309 1.3× 70 0.4× 107 0.6× 61 2.9k
Shawn Doonan Ireland 25 1.3k 0.7× 383 0.8× 139 0.6× 101 0.6× 70 0.4× 103 2.0k
Ernest W. Johns United Kingdom 30 2.4k 1.4× 428 0.9× 83 0.3× 253 1.4× 119 0.7× 44 3.0k
Hiromasa Tojo Japan 32 1.6k 0.9× 170 0.3× 315 1.3× 279 1.5× 160 0.9× 111 2.9k
Darrell Doyle United States 28 1.5k 0.9× 233 0.5× 212 0.9× 490 2.7× 108 0.6× 59 2.5k
Farida S. Sharief United States 18 1.5k 0.9× 178 0.4× 126 0.5× 123 0.7× 171 1.0× 27 2.0k
B. D. Sanwal Canada 38 2.6k 1.5× 241 0.5× 202 0.8× 81 0.4× 229 1.3× 111 3.5k

Countries citing papers authored by A.M. Kroon

Since Specialization
Citations

This map shows the geographic impact of A.M. Kroon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Kroon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Kroon more than expected).

Fields of papers citing papers by A.M. Kroon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Kroon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Kroon. The network helps show where A.M. Kroon may publish in the future.

Co-authorship network of co-authors of A.M. Kroon

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Kroon. A scholar is included among the top collaborators of A.M. Kroon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Kroon. A.M. Kroon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Protasoni, Margherita, et al.. (2020). Mitochondria as target to inhibit proliferation and induce apoptosis of cancer cells: the effects of doxycycline and gemcitabine. Scientific Reports. 10(1). 4363–4363. 74 indexed citations
2.
Protasoni, Margherita, A.M. Kroon, & Jan‐Willem Taanman. (2018). Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3. Oncotarget. 9(73). 33818–33831. 26 indexed citations
3.
Ree, Ronald van, et al.. (1995). Grass pollen immunotherapy induces highly cross‐reactive IgG antibodies to group V allergen from different grass species. Allergy. 50(3). 281–283. 13 indexed citations
4.
Roerdink, Frits H. & A.M. Kroon. (1989). Drug carrier systems. Wiley eBooks. 52 indexed citations
5.
Bogert, Coby Van den, et al.. (1989). Changes in nuclear protein pattern by glucocorticoid treatment of lymphoid cells. Journal of Steroid Biochemistry. 33(5). 955–963. 5 indexed citations
6.
Bogert, Coby Van den, et al.. (1988). Inhibition of mitochondrial protein synthesis influences the glucocorticoid sensitivity of lymphoid cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 972(3). 302–310. 9 indexed citations
7.
Bogert, Coby Van den, et al.. (1988). Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells. Experimental Cell Research. 178(1). 143–153. 45 indexed citations
8.
Kroon, A.M. & Coby Van den Bogert. (1987). Biogenesis of mitochondria and genetics of mitochondrial defects. Journal of Inherited Metabolic Disease. 10(S1). 54–61. 19 indexed citations
9.
Kroon, A.M., et al.. (1984). The antitumour action of doxycycline. 10(11). 759–766. 2 indexed citations
10.
Saccone, Cecilia, Gemma Gadaleta, Cecilia Lanave, et al.. (1982). Rat Mitochondrial DNA: Evolutionary Considerations Based on Nucleotide Sequence Analysis. Cold Spring Harbor Monograph Archive. 12. 121–128. 2 indexed citations
11.
Holtrop, Marijke, et al.. (1979). The biogenesis of rat liver mitochondrial ATPase Subunit composition of the normal ATPase complex and of the deficient complex formed when mitochondrial protein synthesis is blocked. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 548(1). 48–62. 18 indexed citations
12.
Gréco, M., et al.. (1979). The genetic localization of presumptive mitochondrial messenger RNAs on rat-liver mitochondrial DNA. Biochemical and Biophysical Research Communications. 88(1). 199–207. 5 indexed citations
13.
Kroon, A.M., et al.. (1978). PROTECTION OF BONE-MARROW AGAINST TOXIC SIDE-EFFECTS OF TETRACYCLINES. Journal of Molecular Medicine. 3(3). 157–165. 9 indexed citations
14.
Jong, Luitzen de, Marijke Holtrop, & A.M. Kroon. (1978). Oxidative phosphorylation in mitochondria isolated from small intestinal epithelium of thiamphenicol-treated rats and control rats. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 501(3). 405–414. 10 indexed citations
15.
Terpstra, P., Marijke Holtrop, & A.M. Kroon. (1977). A complete cleavage map of Neurospora crassa mtDNA obtained with endonucleases Eco RI and Bam HI. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 475(4). 571–588. 26 indexed citations
16.
Saccone, Cecilia & A.M. Kroon. (1976). The genetic function of mitochondrial DNA : proceedings of the 10th International Bari Conference on the Genetic Function of Mitochondrial DNA, Riva dei Tessali, Italy, 25-29 May 1976. 8 indexed citations
17.
Kroon, A.M., et al.. (1972). Synthesis of 6-14C-ethidium bromide. Analytical Biochemistry. 49(2). 455–458. 4 indexed citations
18.
Vries, H. de & A.M. Kroon. (1970). Euflavin and ethidium bromide; inhibitors of mitochondriogenesis in regenerating rat liver. FEBS Letters. 7(4). 347–350. 25 indexed citations
19.
Borst, Piet & A.M. Kroon. (1969). Mitochondrial DNA: Physicochemical Properties, Replication, and Genetic Function. International review of cytology. 26. 107–190. 143 indexed citations
20.
Kroon, A.M.. (1963). Amino acid incorporation into the protein of mitochondria and mitochondrial fragments from beef heart. Biochimica et Biophysica Acta. 69. 184–185. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isamu Matsumoto Breakdown of academic impact, for papers by Wieland Gevers Breakdown of academic impact, for papers by Richard M. Wright Breakdown of academic impact, for papers by Mary Jane Spiro Breakdown of academic impact, for papers by Shawn Doonan Breakdown of academic impact, for papers by Ernest W. Johns Breakdown of academic impact, for papers by Hiromasa Tojo Breakdown of academic impact, for papers by Darrell Doyle Breakdown of academic impact, for papers by Farida S. Sharief Breakdown of academic impact, for papers by B. D. Sanwal
Rankless by CCL
2026